Comparing Ceriter Stride-One smart insoles with GRAIL gait measurements
Official title: Comparing the Ceriter Stride One, a Pressure-sensitive Smart Insole, With Gait Parameters Measured on the GRAIL in Neurological Populations
Run by University Hospital, Ghent · NCT07237386 · Data updated 2026-11-12
We will test whether Ceriter Stride-One pressure-sensitive insoles give the same gait measurements as the GRAIL system for people with stroke, incomplete spinal cord injury, or acquired/traumatic brain injury who can walk independently for at least six minutes.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent) |
| Status | Recruiting |
| Started | October 15, 2025 |
| Main results expected | September 1, 2026 |
| Study ends | October 1, 2026 |
| Registry record updated | November 19, 2025 |
| Trial ID | NCT07237386 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with central nervous system lesions (stroke, incomplete spinal cord injury, or acquired/traumatic brain injury) receiving care at the Ghent rehabilitation center who can walk independently for at least six minutes are ideal candidates.
✕Probably not a fit
Patients with severe lower-limb orthopedic trauma, body weight over 120 kg, severe dizziness or cardiopulmonary disorders that prevent safe standing/exercise, or who cannot understand the task are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants who are in rehabilitation for stroke, incomplete spinal cord injury, or acquired/traumatic brain injury will wear Ceriter Stride-One smart insoles while undergoing standard gait assessment on the GRAIL instrumented treadmill at UZ Ghent. The study will compare matching parameters such as support phase, swing phase, and left/right leg pressure recorded by the insoles and the GRAIL. Agreement between the two measurement systems will be analyzed to determine the insoles' accuracy. Results will inform whether these insoles can be used reliably in clinical practice and future outpatient or real-world gait monitoring studies.
Why it matters
Potential benefit: If successful, validated insoles could provide accurate, real-world gait data outside the lab to guide personalized rehabilitation and remote monitoring.
How similar studies have gone: Previous studies of wearable pressure insoles have shown reasonable agreement with lab-based gait systems in some populations, but validation specifically in these neurological rehabilitation groups is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Persons suffering a lesion of the central nervous system (stroke, incomplete spinal cord injury, acquired brain injury) who are admitted to the rehabilitation center of the Ghent University hospital or who follow therapy at the rehabilitation center of the Ghent University hospital as outpatients. * Patients need to be able to walk independently during at least 6 minutes without the need of an extra person (Functional ambulation category 3 or higher). Exclusion Criteria: * Severe orthopedic trauma or acute trauma of the lower limbs influencing walking * body weight that exceeds 120 kg. * severe dizziness that makes exercising in standing position impossible * severe cardio-pulmonary disorders that require monitoring during exercising * patients who do not understand the task that needs to be performed in this study.
Where it's running
-
University Hospital Ghent
Ghent, Belgium Recruiting
Study contacts
- Study coordinator: Anke Van Bladel, Professor
- Email: anke.vanbladel@uzgent.be
- Phone: +32468181632
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ZEPU-SG1PLUS Hand Training with Robotic Rehab for Arm Problems
A small study tests whether adding the ZEPU-SG1PLUS robotic hand trainer to standard rehab is safe and helps people with arm problems after stroke, spinal cord injury, brain injury, or orthopedic injuries.
-
Electrical stimulation-assisted exercise for people with lower limb paralysis
This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.
-
ZEPU-2000 robotic rehab for arm and leg weakness
This trial tests whether adding ZEPU-2000A, ZEPU-2000D, and ZEPU-2000E robotic rehabilitation to usual therapy helps adults with arm/leg movement problems from stroke, incomplete SCI, TBI, or related conditions.
-
Home-based vision training guided by brain imaging
This study tests whether at‑home, image-guided visual training can improve visual field function for adults with stroke-related vision loss.
-
Spatial StimelMD for upper-limb recovery after stroke or traumatic brain injury
This trial will test whether adding the Spatial StimelMD device to standard rehabilitation helps adults with upper-limb weakness after stroke or traumatic brain injury improve arm movement.
-
Hypnosis to improve attention and reduce fatigue in stroke, TBI, and MS
This trial tests whether adding hypnosis to standard rehab can help adults with stroke, traumatic brain injury, or multiple sclerosis improve attention and feel less fatigued.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.